Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

.2009 Apr;16(4):446-8.
doi: 10.1038/nsmb.1578. Epub 2009 Mar 29.

CK2alpha phosphorylates BMAL1 to regulate the mammalian clock

Affiliations

CK2alpha phosphorylates BMAL1 to regulate the mammalian clock

Teruya Tamaru et al. Nat Struct Mol Biol.2009 Apr.

Abstract

Clock proteins govern circadian physiology and their function is regulated by various mechanisms. Here we demonstrate that Casein kinase (CK)-2alpha phosphorylates the core circadian regulator BMAL1. Gene silencing of CK2alpha or mutation of the highly conserved CK2-phosphorylation site in BMAL1, Ser90, result in impaired nuclear BMAL1 accumulation and disruption of clock function. Notably, phosphorylation at Ser90 follows a rhythmic pattern. These findings reveal that CK2 is an essential regulator of the mammalian circadian system.

PubMed Disclaimer

Figures

Figure 1
Figure 1. CK2α phosphorylates BMAL1in vitro
A) Mixtures of CK2α (50ng; visible in CBB staining) and CK2β (10ng; visible in autoradiography after phosphorylation) subunits were used inin vitro kinase assay with or without ATP using GST (lane 1) or GST-BMAL1 (lane 2) as substrates.B) CK2α (4 pmol) and CK2β (0-8 pmol) were used in kinase assays with GST-BMAL1 as substrate (500ng; optimal ratio to CK2α) kinase assay. GST-BMAL1 kinase activities (average values) is plotted at each CK2β/CK2α ratio, and normalized against activity in the absence of CK2β with error bars (±SD values). Photographs are representative of duplicate experiments.
Figure 2
Figure 2. CK2α and BMAL1 Ser90 regulate nuclear accumulation and clock function
(A-C)) CK2α silencing/depletion affects BMAL1 nuclear localization and clock function. NIH-3T3 cells were transfected with microRNAi (miR) targeting vectors for mCK2α and the validated negative-control (control) vector, then Dex-synchronized.A) Immunoblot analysis for CK2α and Actin in cell lysates, with one representative experiment shown. Normalized average CK2α levels from triplicate experiments are shown below with error bars (±SD values).B) CircadianmPer2 expression was monitored by a real-time bioluminescence assay. Normalized average values from multiple experiments (n=5) are plotted with error bars (±SD values of 1st/2nd peaks).C) Localization of BMAL1, visualized by immunofluorescence (red) at 24h post Dex treatment. Nuclei were stained with DAPI (blue) and miRNAi-transfected GFP-positive cells (green). Photographs are representative of triplicate experiments. Percentages of cells with BMAL1 predominantly nuclear among the GFP-positive cells from triplicate experiments are plotted as means ± SEM. (***; P < 0.001). (D-F) Mutation of BMAL1 Ser90 affects nuclear localization and clock function.D) Lysates fromBmal1−/− MEFs stably expressing Myc-BMAL1-WT, Myc-BMAL1-S90A and Myc-GFP were analyzed with anti-Myc antibody.E) CircadianmPer2 expression was not restored by BMAL1 S90A, as monitored as was monitored by a real-time bioluminescence assay. Normalized average values from multiple experiments (n=5) are plotted with error bars (±SD values of 1st/2nd peaks).F) MEFs at 24h post Dex treatment were stained with anti-BMAL1 (Green) antibody. Nuclei were stained with DAPI (Blue). Photographs are representative of mutiple (n=4) experiments. Values of nuclear BMAL1-dominant cells (%) in MEFs from multiple (n=4) experiments are plotted as means ± SEM (***; P < 0.001).
Figure 3
Figure 3. Circadian phosphorylation of BMAL1-Ser90 by CK2αin vivo
A) NIH-3T3 cells expressing miR-CK2α and control vector at 24h post Dex treatment were subjected to BMAL1-immunoprecipitation (IP) followed by immunoblot analysis (WB) for BMAL1, P-BMAL1-S90, CK2α and Actin (Lysate). Arrows and bars designate BMAL1 and P-BMAL1-S90.B) BMAL1-immunoprecipitates and lysates of NIH-3T3 cells at each time point post Dex treatment were used in immunoblot analysis for P-BMAL1-S90; BMAL1, PER1, CK2 subunits and Actin. Arrows and bars designate BMAL1 and P-BMAL1-S90. Normalized average values for P-BMAL1-S90 and PER1 from triplicate experiments are plotted in the graph with error bars (±SD values). All the photographs are representative of triplicate experiments.
See this image and copyright information in PMC

References

    1. Reppert SM, Weaver DR. Nature. 2002;418:935–941. - PubMed
    1. Harms E, Kivimae S, Young MW, Saez L. J Biol Rhythms. 2004;19:361–73. - PubMed
    1. Doi M, Hirayama J, Sassone-Corsi P. Cell. 2006;125:497–508. - PubMed
    1. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, et al. Nature. 2007;450:1086–1090. - PubMed
    1. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, et al. Science. 1998;280:1564. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp